Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function

Fig. 5

Distinguishing ability of ICI Score for subgroups of patients with different GC stages. A The difference of ICI Score between GC patients with stage T1-2 and those with stage T3-4; B The proportion of different T stages in the high or low ICI Score groups; C The difference of ICI Score between GC patients with stage N0 and those with stage N1-3; D The proportion of different N stages in the high or low ICI Score groups; E The difference of OS between the high and low ICI Score groups in GC patients with stage T1-2; F The difference of OS between the high and low ICI Score groups in GC patients with stage T3-4; G The difference of OS between the high and low ICI Score groups in GC patients with stage N0; H The difference of OS between the high and low ICI Score groups in GC patients with stage N1-3

Back to article page